Follow us on WhtasApp Channel
Saturday, January 4, 2025
Follow us on Whatsapp Channel

Latest News

Articles -Pharma & Cosmetics

Retail sale: Can we think ‘Pharmacist as Partner’ ?

Dr Arvind Zala Dr Arvind Zala -
Govt Job Alert

CDSCO: 14 vacancies for Drug Controller Positions at senior level

The Health Master The Health Master -
Industry

Action on Misleading Drug Advertisements: Telangana

The Health Master The Health Master -
Industry

Key Notes on Revised Schedule M: Point No. 20 – Computerised systems

Rakesh Dahiya Rakesh Dahiya -
Industry

Spurious drugs seized in Telangana

The Health Master The Health Master -
Industry

Govt bans Nimesulide use in animals: A major step

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 19 – Good practices in quality control

Rakesh Dahiya Rakesh Dahiya -
Industry

US Drug Patent Expirations: A Boon for Indian Pharma

The Health Master The Health Master -
- Advertisement -
Nation

Kolkata raid: Spurious drugs worth Rs 6.6 Crore seized

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 18 – Good practices in production

Rakesh Dahiya Rakesh Dahiya -
Industry

Pharma and Cosmetics Get a Boost as India Reopens Menthol Imports

The Health Master The Health Master -
Industry

Indian Pharma and USFDA Compliance: An Update

The Health Master The Health Master -
Articles -Pharma & Cosmetics

FSSAI: Food Labelling and Display – Chapter-13

Dipika Chauhan Dipika Chauhan -
Industry

Key Notes on Revised Schedule M: Point No. 17 – Documentation

Rakesh Dahiya Rakesh Dahiya -
Health and Fitness

Homoeopathic Doctors can Practice in Allopathy: FDA Maharashtra

The Health Master The Health Master -
Industry

Spurious drugs: Low conviction rate a concern

The Health Master The Health Master -
- Advertisement -
Industry

Drug alert: 111 drug samples declared as NSQ in November 2024

The Health Master The Health Master -
Industry

Key Notes on Revised Schedule M: Point No. 16 – Waste materials

Rakesh Dahiya Rakesh Dahiya -
Industry

USFDA proposes stricter testing for Asbestos in Talcum Powder Cosmetics

The Health Master The Health Master -
Industry

Spurious Drug: New Rules for Medical Stores soon

The Health Master The Health Master -
Industry

CM Haryana assures full support for Karnal Pharma Park

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 15 – Reference Standards

Rakesh Dahiya Rakesh Dahiya -
Industry

USFDA issues EIR to Aarti Drugs for Tarapur facility

The Health Master The Health Master -
Industry

DCA Telangana cracks down on Misleading Drug Advertisements

The Health Master The Health Master -
- Advertisement -
123...383Page 1 of 383

Industry News

CDSCO: 14 vacancies for Drug Controller Positions at senior level

Govt Job AlertThe Health MasterThe Health Master -

Action on Misleading Drug Advertisements: Telangana

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 20 – Computerised systems

IndustryRakesh DahiyaRakesh Dahiya -

Spurious drugs seized in Telangana

IndustryThe Health MasterThe Health Master -

Govt bans Nimesulide use in animals: A major step

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 19 – Good practices in quality control

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

US Drug Patent Expirations: A Boon for Indian Pharma

IndustryThe Health MasterThe Health Master -

Kolkata raid: Spurious drugs worth Rs 6.6 Crore seized

NationThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 18 – Good practices in production

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Pharma and Cosmetics Get a Boost as India Reopens Menthol Imports

IndustryThe Health MasterThe Health Master -

Indian Pharma and USFDA Compliance: An Update

IndustryThe Health MasterThe Health Master -

FSSAI: Food Labelling and Display – Chapter-13

Articles -Pharma & CosmeticsDipika ChauhanDipika Chauhan -

Key Notes on Revised Schedule M: Point No. 17 – Documentation

IndustryRakesh DahiyaRakesh Dahiya -

Spurious drugs: Low conviction rate a concern

IndustryThe Health MasterThe Health Master -

Drug alert: 111 drug samples declared as NSQ in November 2024

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 16 – Waste materials

IndustryRakesh DahiyaRakesh Dahiya -

USFDA proposes stricter testing for Asbestos in Talcum Powder Cosmetics

IndustryThe Health MasterThe Health Master -

Spurious Drug: New Rules for Medical Stores soon

IndustryThe Health MasterThe Health Master -

CM Haryana assures full support for Karnal Pharma Park

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 15 – Reference Standards

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

USFDA issues EIR to Aarti Drugs for Tarapur facility

IndustryThe Health MasterThe Health Master -

DCA Telangana cracks down on Misleading Drug Advertisements

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 14 – Materials

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

USFDA issues VAI status to Biocon for Bengaluru API facility

IndustryThe Health MasterThe Health Master -

Bulk drug import from China continues to rise in 5 years

IndustryThe Health MasterThe Health Master -

High Court stays action against Pharma Units manufacturing Nutraceuticals

IndustryThe Health MasterThe Health Master -

NPPA fixed retail price of 7 formulations: December 2024

IndustryThe Health MasterThe Health Master -

Revised Schedule M: Industry seeks balance between Quality and Viability

IndustryThe Health MasterThe Health Master -

FDA Karnataka enters a New Era of Food and Drug Safety

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 13 – Equipment

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

GST Penalty of Rs. 1.11 Crore on Cipla

IndustryThe Health MasterThe Health Master -

FSSAI regulations on use of Methylcobalamin in Supplements

Health and FitnessThe Health MasterThe Health Master -

FOPE demands inclusion of Sensitive drugs in Schedule P

IndustryThe Health MasterThe Health Master -

Parliamentary Panel demands swift action on Spurious Drugs

IndustryThe Health MasterThe Health Master -

Forms: For Homoeopathy Medicines

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 12 – Premises

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Indian Pharma Market growth: To Reach Rs 2.38 Lakh Crore by 2025

IndustryThe Health MasterThe Health Master -

Over the Counter (OTC) Drug Revolution: New List Coming Soon

IndustryThe Health MasterThe Health Master -

NPPA revised Ceiling price of 13 scheduled formulations: December 2024

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 11 – Personnel

IndustryRakesh DahiyaRakesh Dahiya -

USFDA issued Form 483 with two observations to Aurobindo for API plant

IndustryThe Health MasterThe Health Master -

NPPA fixed retail price of 65 formulations: December 2024

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 10 – Self Inspection

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Medical Device recall: USFDA classifies recall of these catheters as ‘most serious’

IndustryThe Health MasterThe Health Master -

NPPA: New Strategy to Curb Drug Price Hikes

NationThe Health MasterThe Health Master -

Pharmexcil 2024 Elections: New Leadership for India’s Pharmaceutical Industry

NationThe Health MasterThe Health Master -

Drug recall: 1,394 batches of drugs recalled in 2023-24 due to quality issues

NationThe Health MasterThe Health Master -

Chemists want Ayurvedic Medicine Under FDA Scrutiny

IndustryThe Health MasterThe Health Master -

USFDA issues warning letter to Indoco Remedies for Goa facility

IndustryThe Health MasterThe Health Master -

Karnataka creates unified Food and Drug Administration (FDA)

IndustryThe Health MasterThe Health Master -

CDSCO to undergo massive Expansion in the coming year

IndustryThe Health MasterThe Health Master -
Load more

Authors

Rakesh Dahiya
Rakesh Dahiya
145 POSTS0 COMMENTS
Nidhi Gudwani
Nidhi Gudwani
40 POSTS0 COMMENTS
Lalit Kr. Goel
Lalit Kr. Goel
40 POSTS0 COMMENTS
N K Ahooja
N K Ahooja
20 POSTS0 COMMENTS
Dipika Chauhan
Dipika Chauhan
14 POSTS0 COMMENTS
Dr. Kumud Madan
Dr. Kumud Madan
13 POSTS0 COMMENTS
Naripen Goyal
Naripen Goyal
11 POSTS0 COMMENTS
Sushant Mahapatra
Sushant Mahapatra
9 POSTS0 COMMENTS
Dr. Bharatesh R Jagashetty
Dr. Bharatesh R Jagashetty
7 POSTS0 COMMENTS
Dr. B Suresh
Dr. B Suresh
5 POSTS0 COMMENTS
Manmohan Taneja
Manmohan Taneja
5 POSTS0 COMMENTS
Dr. J K Jha
Dr. J K Jha
5 POSTS0 COMMENTS
Dr. BN Nagpal
Dr. BN Nagpal
4 POSTS0 COMMENTS
Dr. Brahmdeep Sindhu
Dr. Brahmdeep Sindhu
4 POSTS0 COMMENTS
H. Mahapatra
H. Mahapatra
3 POSTS0 COMMENTS
Nilesh Gandhi
Nilesh Gandhi
3 POSTS0 COMMENTS
http://www.pharmastute.com
Dr. P K Sreekumar
Dr. P K Sreekumar
2 POSTS0 COMMENTS
Dr. NPS Verma
Dr. NPS Verma
2 POSTS0 COMMENTS
P K Jaggi
P K Jaggi
1 POSTS0 COMMENTS
Sanjay Malhotra
Sanjay Malhotra
1 POSTS0 COMMENTS
http://www.aerolgroup.com
P P Sharma
P P Sharma
1 POSTS0 COMMENTS
Dr. Balraj Yadav
Dr. Balraj Yadav
1 POSTS0 COMMENTS
Dr. Gulshan Rai Arora
Dr. Gulshan Rai Arora
1 POSTS0 COMMENTS
Prof Vivek Padgaonkar
Prof Vivek Padgaonkar
1 POSTS0 COMMENTS
https://www.linkedin.com/in/vivek-padgaonkar-8298509/
Adarsh Goyal
Adarsh Goyal
1 POSTS0 COMMENTS
K C Aggarwal
K C Aggarwal
1 POSTS0 COMMENTS
Dr Arvind Zala
Dr Arvind Zala
1 POSTS0 COMMENTS

Articles; Pharma, Cosmetics, Medical Devices

Retail sale: Can we think ‘Pharmacist as Partner’ ?

Articles -Pharma & CosmeticsDr Arvind ZalaDr Arvind Zala -

Key Notes on Revised Schedule M: Point No. 20 – Computerised systems

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 19 – Good practices in quality control

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 18 – Good practices in production

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

FSSAI: Food Labelling and Display – Chapter-13

Articles -Pharma & CosmeticsDipika ChauhanDipika Chauhan -

Key Notes on Revised Schedule M: Point No. 17 – Documentation

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 16 – Waste materials

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 15 – Reference Standards

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 14 – Materials

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 13 – Equipment

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Forms: For Homoeopathy Medicines

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 12 – Premises

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 11 – Personnel

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 10 – Self Inspection

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 9 – Production under Loan License

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 8 – Change Control

IndustryRakesh DahiyaRakesh Dahiya -

Forms: All types for Hospital RMI

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 7 – Product Recall

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 6 – Complaints and Adverse reaction

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 1 – Pharmaceutical Quality System

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -
Load more

World

Load more

Nation

Load more

State

Load more

Pharmacy Education / Medical Store

Load more

Medical Education / Hospital / Doctors

View All

Govt Job Alert

Load more
spot_img

Health & Fitness

View All

Homoeopathic Doctors can Practice in Allopathy: FDA Maharashtra

The Health Master The Health Master -
Homoeopathic Doctors Homoeopathic Doctors in Maharashtra have been granted the...

FSSAI regulations on use of Methylcobalamin in Supplements

The Health Master The Health Master -
Methylcobalamin The Food Safety and Standards Authority of India...

Naloxone: The Lifesaver You Need to Know About

The Health Master The Health Master -
Naloxone Opioid overdoses are a tragic reality, but they don't...

Chemists demand reversal of Door Step Delivery Order

The Health Master The Health Master -
Door Step Delivery Download the notification G.S.R. 220 (E) dated...
Load more

Articles: Legal

Load more

EDITOR PICKS

Load more

POPULAR POSTS

Load more

POPULAR CATEGORY

ABOUT US

Perfect platform for latest consolidated news, articles, information in the healthcare, medical and pharmaceuticals sectors, including Medical News, Pharmaceutical News, Pharmacy education news, Medical Education news, and many more

Contact us: thehealthmaster19@gmail.com

FOLLOW US

© 2019 - 2024 Website Designed & Managed by The Health Master